Zinc and COVID-19: Basis of Current Clinical Trials.
Biol Trace Elem Res
; 199(8): 2882-2892, 2021 Aug.
Article
in English
| MEDLINE | ID: covidwho-888280
ABSTRACT
Coronavirus disease-2019 (COVID-19) pandemic continues to threaten patients, societies, and economic and healthcare systems around the world. Like many other diseases, the host immune system determines the progress of COVID-19 and fatality. Modulation of inflammatory response and cytokine production using immunonutrition is a novel concept that has been applied to other diseases as well. Zinc, one of the anti-inflammatory and antioxidant micronutrient found in food with well-established role in immunity, is currently being used in some clinical trials against COVID-19. This review integrates the contemporary studies of role of zinc in antiviral immunity along with discussing its potential role against COVID-19, and ongoing COVID-19 clinical trials using zinc.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Zinc
/
COVID-19
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
Biol Trace Elem Res
Year:
2021
Document Type:
Article
Affiliation country:
S12011-020-02437-9
Similar
MEDLINE
...
LILACS
LIS